Plunkett Research Online: Silence Therapeutics PLC

SILENCE THERAPEUTICS PLC (SLNCF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Silence Therapeutics plc is involved in the discovery, development and delivery of novel RNA interference (RNAi) therapeutics for the treatment of serious diseases. The company possesses a comprehensive RNAi therapeutic platforms comprised of proprietary delivery technologies, siRNA sequences and s.....



Silence Therapeutics PLC
Ticker: SLNCF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 2074916520
Fax: 44 2074916521
Address: 72 Hammersmith Road
London, W14 8TH United Kingdom

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
David SolomonCEO/Director
David EllamCFO/Director/Secretary
See More
Silence Therapeutics plc is involved in the discovery, development and delivery of novel RNA interference (RNAi) therapeutics for the treatment of serious diseases. The company possesses a comprehensive RNAi therapeutic platforms comprised of proprietary delivery technologies, siRNA sequences and s.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Covington & Burling LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (GBP)Bonus (GBP)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: